BRUSSELS (AP) — The European Union’s drug regulator insisted Tuesday that there is “no indication” the AstraZeneca vaccine causes blood clots as governments around the world faced the grimmest of dilemmas: push on with a vaccine known to save lives or suspend its use over reports of clotting in some recipients.
The post EU Regulator ‘Convinced’ AstraZeneca Benefit Outweighs Risk appeared first on Khaosod English.